Izidore Lossos, Md
Clinical trials sponsored by Izidore Lossos, Md, explained in plain language.
-
Promising new drug targets rare lymphoma in early trial
Disease control Recruiting nowThis study tests an investigational drug called epcoritamab in 25 adults newly diagnosed with marginal zone lymphoma, a slow-growing blood cancer. The goal is to see if the drug can shrink or eliminate tumors. Participants will receive the drug for several cycles, and doctors wil…
Phase: PHASE2 • Sponsor: Izidore Lossos, MD • Aim: Disease control
Last updated May 26, 2026 12:00 UTC
-
New drug mosunetuzumab aims to control rare lymphoma without chemo
Disease control Recruiting nowThis study tests a new drug called mosunetuzumab in people with a rare type of lymphoma (EMZL) who have not had any prior cancer treatment. The goal is to see if the drug can shrink or eliminate the cancer and how safe it is. About 35 adults with stage I to IV disease will partic…
Phase: PHASE2 • Sponsor: Izidore Lossos, MD • Aim: Disease control
Last updated May 14, 2026 12:02 UTC